A detailed history of American Portfolios Advisors transactions in Omnicell, Inc stock. As of the latest transaction made, American Portfolios Advisors holds 3,087 shares of OMCL stock, worth $83,565. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,087
Holding current value
$83,565
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$86.3 - $117.38 $266,408 - $362,352
3,087 New
3,087 $269 Million
Q2 2022

Mar 20, 2023

BUY
$105.64 - $129.11 $10,035 - $12,265
95 Added 3.08%
3,182 $362 Million
Q1 2022

Mar 21, 2023

BUY
$120.68 - $180.51 $15,085 - $22,563
125 Added 4.05%
3,212 $416 Million
Q4 2021

Mar 21, 2023

BUY
$153.26 - $183.62 $906,073 - $1.09 Million
5,912 Added 191.51%
8,999 $1.62 Billion
Q3 2021

Mar 22, 2023

BUY
$141.84 - $160.88 $874,869 - $992,307
6,168 Added 199.81%
9,255 $1.37 Billion
Q2 2021

Mar 22, 2023

SELL
$129.91 - $151.45 $13,120 - $15,296
-101 Reduced 3.27%
2,986 $452 Million
Q1 2021

Mar 22, 2023

SELL
$117.78 - $143.9 $114,599 - $140,014
-973 Reduced 31.52%
2,114 $275 Million
Q4 2020

Mar 22, 2023

SELL
$73.85 - $120.02 $217,340 - $353,218
-2,943 Reduced 95.34%
144 $17.3 Million
Q3 2020

Mar 22, 2023

SELL
$63.15 - $77.12 $190,649 - $232,825
-3,019 Reduced 97.8%
68 $5.08 Million
Q2 2020

Mar 24, 2023

SELL
$59.36 - $74.43 $181,285 - $227,309
-3,054 Reduced 98.93%
33 $2.33 Million
Q4 2019

Mar 24, 2023

SELL
$70.15 - $83.11 $195,508 - $231,627
-2,787 Reduced 90.28%
300 $24.5 Million
Q3 2019

Mar 24, 2023

SELL
$68.36 - $88.34 $2,802 - $3,621
-41 Reduced 12.02%
300 $21.7 Million
Q2 2019

Mar 24, 2023

SELL
$71.38 - $92.21 $196,009 - $253,208
-2,746 Reduced 88.95%
341 $29.3 Million
Q4 2018

Mar 24, 2023

SELL
$56.97 - $77.23 $156,439 - $212,073
-2,746 Reduced 88.95%
341 $20.9 Million

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.2B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.